Why is monitoring serum phosphorus important in PD patients?

• A. Hyperphosphatemia contributes to bone-mineral disease; manage with dietary control and phosphate binders; monitor calcium and PTH.
• B. Phosphorus levels are not relevant in PD.
• C. Monitor phosphorus primarily to adjust insulin dosing.
• D. Phosphorus levels are used to determine dialysate volume.

Answer: (A)

High serum phosphorus signals a disruption in mineral balance common in dialysis patients. In end-stage kidney failure, the kidneys can’t excrete phosphate effectively, so levels rise. If phosphorus stays elevated, it drives secondary hyperparathyroidism and bone-mineral disorders, and it promotes vascular and soft-tissue calcifications, which increase cardiovascular risk.

Therefore, monitoring phosphorus helps guide treatment: reducing dietary phosphate intake, using phosphate binders with meals to limit absorption, and optimizing dialysis to remove more phosphate as needed. Monitoring calcium and PTH alongside phosphorus is important because they interact with phosphate in regulating bone turnover and mineral balance; keeping all three in target ranges supports bone health and lowers calcification risk.

The other options aren’t correct because phosphorus levels are relevant in PD, they’re not used to adjust insulin dosing, and they don’t determine dialysate volume.